1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Despite the many advances in cardiovascular medicine, decisions concerning the
diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain …

Aims Current guidelines recommend anticoagulation with a vitamin K antagonist to treat left
ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral …

Current American College of Cardiology/American Heart Association guidelines for stroke or
ST-elevation myocardial infarction recommend the use of oral vitamin K antagonists (VKAs) …

Background There is increasing interest in direct oral anticoagulants (DOACs), given their
safety and convenience in atrial fibrillation, compared with vitamin K antagonists (VKAs) …

Heart failure (HF) is a clinical syndrome that is divided into 3 subtypes based on the left
ventricular ejection fraction. Every subtype has specific clinical characteristics and …

Background Patients with left ventricular thrombus are at high risk for ischemic stroke and
systemic embolization. The mainstay of treatment is anticoagulation, but it remains unclear if …

Aims A left ventricular thrombus (LVT) is not uncommon in patients with impaired LV systolic
function. However, the treatment strategy for LVT has not yet been fully established. We …

Left ventricular thrombi (LVTs) increase the risk of stroke, systemic embolism, and
subsequent death. Current guidelines recommend vitamin K antagonists (VKAs) as first-line …